Antwerp, Belgium

Wander Van Breedam

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: University of Ghent, Vib Vzw. Active years: 2024-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovations by Wander Van Breedam in Glycosylation Technology**

Introduction

Wander Van Breedam is a prominent inventor based in Antwerp, Belgium, known for his significant contributions to the field of biotechnology. With a total of two patents, he has made remarkable strides in genetically engineered eukaryotic cells and glycoprotein technology, focusing on advancing methodologies that have implications in various biopharmaceutical applications.

Latest Patents

His latest patents include groundbreaking work on "Genetically engineered eukaryotic cells producing LacNAc-glycoproteins," which provides methods for producing homogeneous forms of small glycan structures carrying terminal galactose residues. This innovation offers glycan-conjugates based on specific couplings with galactose residues found on recombinant glycoproteins. Additionally, he has developed a patent for "Glycosylation of variable immunoglobulin domains," which features nucleotide sequences that encode polypeptides with engineered glycosylation acceptor sites. This patent focuses on immunoglobulin variable domain proteins modified with selected glycans, enhancing their functionality in therapeutic applications.

Career Highlights

Wander has worked with notable organizations, including Vib Vzw and Universiteit Gent. His professional journey reflects a commitment to advancing science and technology within the biotechnology sector. His work has contributed significantly to the understanding and application of glycosylation processes in immunotherapy and vaccine development.

Collaborations

Throughout his career, Wander has collaborated with esteemed colleagues, such as Nico Callewaert and Bram Laukens. These partnerships have fostered a productive research environment conducive to innovation and the development of new technologies in the realm of glycosylation.

Conclusion

Wander Van Breedam's contributions to biotechnology through his innovative patents and collaborative efforts underline the importance of ongoing research in the field. His work in glycosylation technology not only advances scientific knowledge but also paves the way for future innovations in therapeutics and biotechnology applications, thereby enhancing human health and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…